Interesting links
Here are some interesting links for you! Enjoy your stay :)Pages
- A Targeted Metabolomics-Based Assay Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity Potential
- About Stemina
- Application of the Biomarker-Based In Vitro Assays devTOX quickPredict and Cardio quickPredict for Toxicity Screening
- Archive
- Board of Directors
- Cardio quickPredict
- Careers
- Contact
- Custom Services
- Defining the Reproducibility and Applicability Domain of devTOX quickPredict, a Human Pluripotent Stem Cell-Based Developmental Toxicity Assay
- Developmental Computation with Embryonic Stem Cells
- devTOX quickPredict FAQs
- Home
- In Vitro to In Vivo Extrapolation for Developmental Toxicity Potency of Valproate Analogues
- Journal Publications
- Leadership
- Neurodevelopmental Division
- News
- Posters
- Predicting Developmental Toxicity Potential Using Pluripotent Embryonic Stem Cell Assays and the ToxCast Library
- Presentations
- Press Releases
- Privacy Policy
- Resources
- Scientific Advisory Board
- Upcoming Events
- Webinars
- devTox quickPredict
Categories
Archive
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- August 2021
- March 2021
- February 2021
- November 2020
- October 2020
- April 2020
- March 2020
- February 2020
- November 2019
- June 2019
- March 2019
- November 2018
- October 2018
- September 2018
- July 2018
- June 2018
- March 2018
- February 2018
- January 2018
- November 2017
- October 2017
- September 2017
- August 2017
- June 2017
- March 2017
- February 2017
- January 2017
- November 2016
- October 2016
- July 2016
- May 2016
- March 2016
- November 2015
- June 2015
- March 2015
- August 2014
- March 2014
- January 2014
- November 2013
- September 2013
- August 2013
- June 2013
- March 2013
- February 2013
- November 2012
- August 2012
- January 2012
- November 2011
- August 2010
- June 2010
- May 2010
- September 2009
- June 2009
- December 2007
Evaluation of the reference chemicals suggested in the draft ICH S5(R3) guideline with a human pluripotent stem cell-based developmental toxicity assay [SOT, 2019]
Presented at the Society of Toxicology Annual Meeting and ToxExpo in Baltimore, Maryland; March 2019.
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) recently released the draft S5(R3) Guideline on Detection of Toxicity to Reproduction for Human Pharmaceuticals. The revised guideline would allow the use of in vitro, ex-vivo, and non-mammalian in vivo embryo-fetal development alternative assays to replace or eliminate in vivo studies in certain circumstances and provides a framework for qualifying alternative test systems for regulatory acceptance.
Predicting Tyrosine Kinase Inhibitor Cardiotoxicity with a Biomarker-Based Human iPSC-Derived Cardiomyocyte Assay [SOT, 2019]
Presented at the Society of Toxicology Annual Meeting and ToxExpo in Baltimore, Maryland; March 2019.
Tyrosine kinase inhibitors (TKI) have greatly improved the treatment and prognosis for a wide range of cancers but often cause cardiotoxic effects. We developed an in vitro assay, Cardio quickPredict, for predicting cardiovascular liability based on changes in human iPSC-derived cardiomyocytes (iPSC-CM) metabolism and cell viability, which identifies both functional and structural cardiotoxicants.
Identify Functional and Structural Cardiotoxicants with the Biomarker-Based Cardio quickPredictTM Assay [SOT, 2019]
Presented at the Society of Toxicology Annual Meeting and ToxExpo in Baltimore, Maryland; March 2019.
Preclinical cardiac safety evaluations are heavily focused on electrophysiological assessment and often fail to identify structural cardiotoxicants. Stemina’s Cardio quickPredict assay accurately identifies compounds that elicit both structural and/or functional cardiotoxic effects. We will discuss how the assay can be used for early cardiac safety assessment.
Prediction of Cardiotoxicity Potential Using Targeted Metabolomics and Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes [SPS, 2018]
Presented at the Safety Pharmacology Annual Meeting in Washington, DC; September/October 2018
Cardiac safety is one of the leading causes of late-stage compound attrition in the pharmaceutical industry and accounts for 28% if safety-related withdrawals of FDA-approved drugs from the market. Current cardiac safety preclinical evaluations are heavily focused on electrophysiological assessment and fail to evaluate cardiomyopathy and other forms of structural cardiotoxicity…
Cardio quickPredict: A New Way to Evaluate Cardiotoxicity Potential [SOT 2018 – Presentation Slides]
Presented at the Society of Toxicology Annual Meeting and ToxEXPO in San Antonio, Texas, March 2018 by Stemina’s Associate Director of Toxicology, Jessica Palmer.Predicting cardiotoxicity remains a challenge. Cardiovascular toxicity is a major cause leading to compound attrition throughout the drug discovery and development process as well as withdrawal of FDA-approved drugs from the market…
Application of a Human Pluripotent Stem Cell-Based Assay for Developmental Toxicity Screening [Tox Forum 2018 – Presentation Slides]
Presented at The Toxicology Forum’s 42nd Annual Winter Meeting in Washington, DC in January 2018 by Stemina’s Associate Director of Toxicology, Jessica Palmer.
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) recently released the draft S5(R3) Guideline on Detection of Toxicity to Reproduction for Human Pharmaceuticals…
Developmental Toxicity Potency of Valproate Analogues in a Human Pluripotent Stem Cell-Based Assay -[Northland Chapter of SOT, 2017 – Slides]
Presented at the Annual Meeting of the Northland Chapter of the Society of Toxicology (September 2017) by Jessica Palmer, Associate Director of Toxicology.
Development and validation of alternative models for developmental toxicity testing is essential for reducing the number of animals used for toxicity testing. While replacing animal models has been at the forefront of the toxicology field for over a decade…
Prediction of Developmental Toxicity Potential Dictated by In Vivo Exposures with a Biomarker-Based Human Pluripotent Stem Cell Assay – [Teratology Society 2017 – Slides]
Presented at the Teratology Society’s 57th Annual Meeting in Denver, Colorado in June 2017 by Stemina’s Associate Director of Toxicology, Jessica Palmer.
Previous approaches for evaluating the accuracy of alternative test methods have been based on the classification of a chemical as either a positive or negative, with no other distinction…